← All companies
AstraZeneca PLC
AZN
Market cap$286.27 B
Rank#45
SEC filings1,004
The table below shows AstraZeneca PLC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $11.98B | $10.76B | $9.46B | $7.77B | $6.03B | $5.29B |
| R&D | $3.55B | $3.01B | $2.67B | $2.55B | $1.83B | $1.39B |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.